HR 4376
USTRx Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, titled the USTRx Act, aims to address what Congress sees as unfair practices by high-income countries regarding pharmaceutical pricing and trade. It establishes a Chief Pharmaceutical Trade Negotiator within the U.S. Trade Representative’s office to specifically focus on pharmaceutical trade issues and advocate for U.S. manufacturers. The bill requires an annual report identifying high-income countries and assessing their pharmaceutical policies for potential negative impacts on innovation and market access, and mandates a response plan if harmful practices are found.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.